Research Progress in the Association between Amino Acid Metabolism of Oral Microorganisms and Host Cells and Oral Diseases
Abstract
Amino acids, the substrate of protein synthesis, are an important source of energy and nutrition, second only to glucose. Previous studies have found that both microorganisms and their host cells can metabolize amino acids, and the metabolites are widely involved in the regulation of various biological processes, including inflammation and immune response. Exploring the changes in amino acid metabolism during the pathogenesis and progression of diseases has become a new hot topic of research. We summarized in this review the research progress in the pathogenesis and progression of common oral diseases, including dental caries, periodontal diseases, Sjögren’s syndrome, and even oral tumors, related to metabolism pathways of amino acids, especially tryptophan and arginine, and their metabolites, attempting to provide a theoretical basis for enhancing understanding of the pathogenic mechanism of the oral diseases, as well as guidance for clinical treatment.
Keywords: Amino acid metabolism, Dental caries, Periodontal disease, Sjögren’s syndrome, Tryptophan, Arginine
Full Text:
PDFReferences
ZHANG Y， WANG X， LI H， et al. Human oral microbiota and its modulation for oral health. Biomed Pharmacother，2018，99: 883–893.
DHANKHAR R， GUPTA V， KUMAR S， et al. Microbial enzymes for deprivation of amino acid metabolism in malignant cells: Biological strategy for cancer treatment. Appl Microbiol Biotechnol，2020，104(7): 2857–2869.
COSTANTINI C， BELLET M M， RENGA G， et al. Tryptophan co-metabolism at the host-pathogen interface. Front Immunol， 2020， 11: 67[2021-11-19]. https://doi.org/10.3389/fimmu.2020.00067.
BARIK S. The uniqueness of tryptophan in biology: Properties, metabolism, interactions and localization in proteins. Int J Mol Sci，2020，21(22): 8776.
PALEGO L， BETTI L， ROSSI A， et al. Tryptophan biochemistry: structural， nutritional， metabolic， and medical aspects in humans. J Amino Acids， 2016， 2016: 8952520[2021-11-19]. https://www. hindawi.com/journals/jaa/2016/895252. doi: 10.1155/2016/8952520.
DONG F， PERDEW G H. The aryl hydrocarbon receptor as a mediator of host-microbiota interplay. Gut Microbes， 2020， 12(1): 1859812[2021-11-19]. https://www.tandfonline.com/doi/full/10.1080/19490976.2020. doi: 10.1080/19490976.2020.1859812.
TAKAHASHI N. Oral microbiome metabolism: from "who are they"? to "what are they doing"? J Dent Res，2015，94(12): 1628–1637.
GRIFKA-WALK H M， JENKINS B R， KOMINSKY D J. Amino acid trp: The far out impacts of host and commensal tryptophan metabolism. Front Immunol， 2021， 12: 653208[2021-11-19]. https://www.frontiersin. org/articles/10.3389/fimmu.2021.653208/full. doi: 10.3389/fimmu.2021. 653208.
WU H， DENNA T H， STORKERSEN J N， et al. Beyond a neurotransmitter: the role of serotonin in inflammation and immunity. Pharmacol Res，2019，140: 100–114.
SHAJIB M S， KHAN W I. The role of serotonin and its receptors in activation of immune responses and inflammation. Acta Physiol (Oxf)， 2015，213(3): 561–574.
BADAWY A A. Kynurenine pathway of tryptophan metabolism: Regulatory and functional aspects. Int J Tryptophan Res， 2017， 10: 1178646917691938[2021-11-19]. https://journals.sagepub.com/doi/metrics/10.1177/1178646917691938. doi: 10.1177/1178646917691938.
LIU X H， ZHAI X Y. Role of tryptophan metabolism in cancers and therapeutic implications. Biochimie，2021，182: 131–139.
YUASA H J， BALL H J. Efficient tryptophan-catabolizing activity is consistently conserved through evolution of TDO enzymes, but not IDO enzymes. J Exp Zool B Mol Dev Evol，2015，324(2): 128–140.
PFEFFERKORN E R. Interferon gamma blocks the growth of Toxoplasma gondii in human fibroblasts by inducing the host cells to degrade tryptophan. Proc Natl Acad Sci U S A，1984，81(3): 908–912.
CHOERA T， ZELANTE T， ROMANI L， et al. A multifaceted role of tryptophan metabolism and indoleamine 2，3-dioxygenase activity in aspergillus fumigatus-host interactions. Front Immunol， 2017， 8: 1996[2021-11-19]. https://www.frontiersin.org/articles/10.3389/fimmu.2017.01996/full. doi: 10.3389/fimmu.2017.01996.
NEAVIN D R， LIU D， RAY B， et al. The role of the aryl hydrocarbon receptor (AHR) in immune and inflammatory diseases. Int J Mol Sci， 2018，19(12): 3851.
DURAN-PINEDO A E， FRIAS-LOPEZ J. Beyond microbial community composition: Functional activities of the oral microbiome in health and disease. Microbes Infect，2015，17(7): 505–516.
BALCI N， KURGAN S， CEKICI A， et al. Free amino acid composition of saliva in patients with healthy periodontium and periodontitis. Clin Oral Investig，2021，25(6): 4175–4183.
WANG W， WANG X， LU S， et al. Metabolic disturbance and Th17/Treg ombalance are associated with progression of gingivitis. Front Immunol， 2021， 12: 670178[2021-11-19]. https://www.frontiersin. org/articles/10.3389/fimmu.2021.670178/full. doi: 10.3389/fimmu. 2021.670178.
MOON J S， CHEONG N R， YANG S Y， et al. Lipopolysaccharide-induced indoleamine 2,3-dioxygenase expression in the periodontal ligament. J Periodontal Res，2013，48(6): 733–739.
QIN X， LIU J Y， WANG T， et al. Role of indoleamine 2,3-dioxygenase in an inflammatory model of murine gingiva. J Periodontal Res，2017， 52(1): 107–113.
NISAPAKULTORN K， MAKRUDTHONG J， SA-ARD-IAM N， et al. Indoleamine 2,3-dioxygenase expression and regulation in chronic periodontitis. J Periodontol，2009，80(1): 114–121.
CHABBI-ACHENGLI Y， COUDERT A E， CALLEBERT J， et al. Decreased osteoclastogenesis in serotonin-deficient mice. Proc Natl Acad Sci U S A，2012，109(7): 2567–2572.
LI X， MA Y， WU X， et al. Serotonin acts as a novel regulator of interleukin-6 secretion in osteocytes through the activation of the 5-HT(2B) receptor and the ERK1/2 signalling pathway. Biochem Biophys Res Commun，2013，441(4): 809–814.
LI X， WU X， MA Y， et al. Oral administration of 5-hydroxytryptophan aggravated periodontitis-induced alveolar bone loss in rats. Arch Oral Biol，2015，60(5): 789–798.
SRIVASTAVA A， MAKARENKOVA H P. Innate immunity and biological therapies for the treatment of Sjogren’s Syndrome. Int J Mol Sci，2020，21(23): 9172.
KAGEYAMA G， SAEGUSA J， IRINO Y， et al. Metabolomics analysis of saliva from patients with primary Sjogren’s syndrome. Clin Exp Immunol，2015，182(2): 149–153.
HERRALA M， MIKKONEN J J W， PESONEN P， et al. Variability of salivary metabolite levels in patients with Sjogren’s syndrome. J Oral Sci， 2020，63(1): 22–26.
FERNANDEZ-OCHOA A， BORRAS-LINARES I， QUIRANTES-PINE R， et al. Discovering new metabolite alterations in primary Sjogren’s syndrome in urinary and plasma samples using an HPLC-ESI-QTOF-MS methodology. J Pharm Biomed Anal， 2020， 179: 112999[2021-11-19]. https://doi.org/10.1016/j.jpba.2019.112999.
DE OLIVEIRA F R， FANTUCCI M Z， ADRIANO L， et al. Neurological and inflammatory manifestations in Sjogren’s Syndrome: the role of the kynurenine metabolic pathway. Int J Mol Sci，2018，19(12): 3953.
MARIA N I， VAN HELDEN-MEEUWSEN C G， BRKIC Z， et al. Association of increased Treg cell levels with elevated indoleamine 2,3-dioxygenase activity and an imbalanced kynurenine pathway in interferon-positive primary Sjogren’s syndrome. Arthritis Rheumatol， 2016，68(7): 1688–1699.
RUBEL F， KERN J S， TECHNAU-HAFSI K， et al. Indoleamine 2,3-dioxygenase expression in primary cutaneous melanoma correlates with
Refbacks
- There are currently no refbacks.
